Strategies to produce hepatocytes and hepatocyte-like cells from pluripotent stem cells

Hepatology Research

Volumn 42, Issue 2, 2012, Pages 111-119

  Chistiakov, Dimitry A ^a   Chistiakov, Pavel A ^b  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

Author keywords

Definitive endoderm; Directed differentiation; Embryonic stem cell; Hepatocyte; Induced pluripotent stem cell

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; CHEMOKINE RECEPTOR CXCR4; CONNEXIN 32; CYTOCHROME P450; CYTOKERATIN 19; CYTOKERATIN 7; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 8; GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 6; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PREALBUMIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR SOX17; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

BIOARTIFICIAL LIVER; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL THERAPY; CHRONIC LIVER DISEASE; EMBRYO DEVELOPMENT; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDODERM; HUMAN; LIVER CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE SPECIFICITY;

EID: 84855953166     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00896.x     Document Type: Review

References (76)

1. Maurel P. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Adv Drug Deliv Rev 1996; 22: 105-32.
2. Chamuleau RAFM, Deurholt T, Hoekstra R. Which are the right cells to be used in a bioartificial liver? Metab Brain Dis 2005; 20: 327-35.
3. Méndez-Sanchez N, Chávez-Tapia NC, Uribe M. Hepatocyte transplantation for acute and chronic liver diseases. Ann Hepatol 2005; 4: 212-15.
4. Ellor S, Shupe T, Petersen B. Stem cell therapy for inherited metabolic disorders of the liver. Exp Hematol 2008; 36: 716-25.
5. Rossant J. Stem cells and early lineage development. Cell 2008; 132: 527-31.
6. Jones EA, Tosh D, Wilson DI, Lindsay S, Forrester LM. Hepatic differentiation of murine embryonic stem cells. Exp Cell Res 2002; 272: 15-22.
7. Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 2003; 12: 1-11.
8. Thomson JA, Itskovitz-Eldor J, Shapiro SS etal. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7.
9. Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008; 9: 725-9.
10. Takahashi K, Tanabe K, Ohnuki M etal. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
11. Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010; 24: 2239-63.
12. Aoi T, Yae K, Nakagawa M etal. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008; 321: 699-702.
13. Liu H, Ye Z, Kim Y, Sharkis S, Jang YY. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 2010; 51: 1810-19.
14. Song Z, Cai J, Liu Y etal. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009; 19: 1233-42.
15. Gai H, Nguyen DM, Moon YJ etal. Generation of murine hepatic lineage cells from induced pluripotent stem cells. Differentiation 2010; 79: 171-81.
16. Si-Tayeb K, Noto FK, Nagaoka M etal. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010; 51: 297-305.
17. Iwamuro M, Komaki T, Kubota Y etal. Hepatic differentiation of mouse iPS cells in vitro. Cell Transplant 2010; 19: 841-7.
18. Polo JM, Liu S, Figueroa ME, Kulalert W etal. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010; 28: 848-55.
19. Hu A, Cai J, Zheng Q, He X, Pan Y, Li L. Hepatic differentiation from embryonic stem cells in vitro. Chin Med J (Engl) 2003; 116: 1893-7.
20. Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB, Samarut J. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates d-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 1996; 12: 309-22.
21. Park JH, Kim SJ, Oh EJ etal. Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biol Reprod 2003; 69: 2007-14.
22. Stacey GN, Cobo F, Nieto A, Talavera P, Healy L, Concha A. The development of "feeder" cells for the preparation of clinical grade hES cell lines: challenges and solutions. J Biotechnol 2006; 125: 583-8.
23. Stojkovic P, Lako M, Stewart R etal. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells 2005; 23: 306-14.
24. Amit M, Itskovitz-Eldor J. Maintenance of human embryonic stem cells in animal serum- and feeder layer-free culture conditions. Methods Mol Biol 2006; 331: 105-13.
25. Vallier L, Alexander M, Pedersen RA. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 2005; 118: 4495-509.
26. Wang G, Zhang H, Zhao Y etal. Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem Biophys Res Commun 2005; 330: 934-42.
27. Wang L, Schulz TC, Sherrer ES etal. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 2007; 110: 4111-19.
28. Itskovitz-Eldor J, Schuldiner M etal. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000; 6: 88-95.
29. Chinzei R, Tanaka Y, Shimizu-Saito K etal. Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology 2002; 36: 22-9.
30. Choi D, Lee HJ, Jee S etal. In vitro differentiation of mouse embryonic stem cells: enrichment of endodermal cells in the embryoid body. Stem Cells 2005; 23: 817-27.
31. Hu AB, Cai JY, Zheng QC etal. High-ratio differentiation of embryonic stem cells into hepatocytes in vitro. Liver Int 2004; 24: 237-45.
32. Soto-Gutierrez A, Navarro-Alvarez N, Caballero-Corbalan J, Tanaka N, Kobayashi N. Endoderm induction for hepatic and pancreatic differentiation of ES cells. Acta Med Okayama 2008; 62: 63-8.
33. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005; 23: 1534-41.
34. Kreidl E, Oztürk D, Metzner T, Berger W, Grusch M. Activins and follistatins: Emerging roles in liver physiology and cancer. World J Hepatol 2009; 1: 17-27.
35. Kubo A, Shinozaki K, Shannon JM etal. Development of definitive endoderm from embryonic stem cells in culture. Development 2004; 131: 1651-62.
36. Roelandt P, Pauwelyn KA, Sancho-Bru P etal. Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells. PLoS ONE 2010; 5: e12101.
37. Sekhon SS, Tan X, Micsenyi A, Bowen WC, Monga SP. Fibroblast growth factor enriches the embryonic liver cultures for hepatic progenitors. Am J Pathol 2004; 164: 2229-40.
38. Schmidt C, Bladt F, Goedecke S etal. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699-702.
39. Schoneveld OJ, Gaemers IC, Lamers WH. Mechanisms of glucocorticoid signalling. Biochim Biophys Acta 2004; 1680: 114-28.
40. Kinoshita T, Sekiguchi T, Xu MJ etal. Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc Natl Acad Sci U S A 1999; 96: 7265-70.
41. Brolén G, Sivertsson L, Björquist P etal. Hepatocyte-like cells derived from human embryonic stem cells specifically via definitive endoderm and a progenitor stage. J Biotechnol 2010; 145: 284-94.
42. Funakoshi N, Duret C, Pascussi JM etal. Comparison of hepatic-like cell production from human embryonic stem cells and adult liver progenitor cells: CAR transduction activates a battery of detoxification genes. Stem Cell Rev 2011; 7: 518-31.
43. Agarwal S, Holton KL, Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008; 26: 1117-27.
44. Hay DC, Zhao D, Ross A, Mandalam R, Lebkowski J, Cui W. Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells 2007; 9: 51-62.
45. Min J, Shang CZ, Chen YJ etal. Selective enrichment of hepatocytes from mouse embryonic stem cells with a culture system containing cholestatic serum. Acta pharmacol Sin 2007; 28: 1931-7.
46. Zhao D, Chen S, Cai J etal. Derivation and characterization of hepatic progenitor cells from human embryonic stem cells. PLoS ONE 2009; 4: e6468.
47. Touboul T, Hannan NR, Corbineau S etal. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 2010; 51: 1754-65.
48. Bararvand H, Hashemi SM, Kazemi Ashtiani S, Farrokhi A. Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol 2006; 50: 645-52.
49. Liu T, Zhang S, Chen X, Li G, Wang Y. Hepatic differentiation of mouse embryonic stem cells in three-dimensional polymer scaffolds. Tissue Eng Part A 2010; 16: 1115-22.
50. Fang S, Qiu YD, Mao L, Shi XL, Yu DC, Ding YT. Differentiation of embryoid-body cells derived from embryonic stem cells into hepatocytes in alginate microbeads in vitro. Acta pharmacol Sin 2007; 28: 1924-30.
51. Tada S, Era T, Furusawa C etal. Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development 2005; 132: 4363-74.
52. Yasunaga M, Tada S, Torikai-Nishikawa S etal. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 2005; 23: 1542-50.
53. Gouon-Evans V, Boussemart L, Gadue P etal. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 2006; 24: 1402-11.
54. Lemaigre F, Zaret KS. Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr Opin Genet Dev 2004; 14: 582-90.
55. Nava S, Westgren M, Jaksch M etal. Characterization of cells in the developing human liver. Differentiation 2005; 73: 249-60.
56. Donato MT, Lahoz A, Montero S etal. Functional assessment of the quality of human hepatocyte preparations for cell transplantation. Cell Transplant 2008; 17: 1211-19.
57. Bonora-Centelles A, Donato MT, Lahoz A etal. Functional characterization of hepatocytes for cell transplantation: customized cell preparation for each receptor. Cell Transplant 2010; 19: 21-8.
58. Tabei I, Hashimoto H, Ishiwata I etal. New approach for the establishment of a hepatocyte cell line derived from rat early embryonic stem cells. Hum Cell 2003; 16: 39-46.
59. Conley BJ, Young JC, Trounson AO, Mollard R. Derivation, propagation and differentiation of human embryonic stem cells. Int J Biochem Cell Biol 2004; 36: 555-67.
60. Cai J, Zhao Y, Liu Y etal. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007; 45: 1229-39.
61. Weigel PH, Yik JH. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim Biophys Acta 2002; 1572: 341-63.
62. Basma H, Soto-Gutiérrez A, Yannam GR etal. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009; 136: 990-9.
63. Hong H, Takahashi K, Ichisaka T etal. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009; 460: 1132-5.
64. Utikal J, Polo JM, Stadtfeld M etal. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009; 460: 1145-8.
65. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-53.
66. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458: 771-5.
67. Woltjen K, Michael IP, Mohseni P etal. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458: 766-70.
68. Kim JB, Sebastiano V, Wu G etal. Oct4-induced pluripotency in adult neural stem cells. Cell 2009; 136: 411-19.
69. Huang P, He Z, Ji S etal. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011; 475: 386-9.
70. Sekiya S, Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011; 475: 390-3.
71. Iacob R, Rüdrich U, Rothe M etal. Induction of a mature hepatocyte phenotype in adult liver derived progenitor cells by ectopic expression of transcription factors. Stem. Cell Res 2011; 6: 251-61.
72. Takayama K, Inamura M, Kawabata K etal. Efficient and directive generation of two distinct endoderm lineages from human ESCs and iPSCs by differentiation stage-specific SOX17 transduction. PLoS ONE 2011; 6: e21780.
73. Inamura M, Kawabata K, Takayama K etal. Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX. Mol Ther 2011; 19: 400-7.
74. Anderson DG, Burdick JA, Langer R. Smart biomaterials. Science 2004; 305: 1923-4.
75. Wang S, Nagrath D, Chen PC, Berthiaume F, Yarmush ML. Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng Part A 2008; 14: 227-36.
76. Semino CE, Merok JR, Crane GG, Panagiotakos G, Zhang S. Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation 2003; 71: 262-70.